Company intelligence / Profile preview

Orpyx Medical Technologies

Calgary, Alberta, Canadaorpyx.com ↗

Ownership: Private
Employees: ~51
Development stage: Other

Overview

The company’s flagship product—the Orpyx Sensory Insole system—has demonstrated an 86% reduction in diabetic foot ulcer recurrence when worn for at least 4.5 hours per day in a randomized controlled trial. The device provides continuous remote monitoring of plantar pressure and temperature to proactively prevent diabetic foot ulcers and related complications[9].

Therapeutic areas: Endocrinology
Modalities: Device
Industry: Physiological Monitoring

Partnerships

Perceptive Advisors (lead investor/strategic partner)US health plans and the Veterans Health Administration

Beyond the preview

Go deeper on Orpyx Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Orpyx Medical Technologies.

Explore the full profile